Evidence map›Paper›PMID 36944956›Full record

ArticleNutrition & metabolism2023

Effect of different doses of Lacticaseibacillus paracasei K56 on body fat and metabolic parameters in adult individuals with obesity: a pilot study.

Guzailinuer Kadeer, Wanrui Fu, Yaqi He, Ying Feng, Wei-Hsein Liu, Wei-Lian Hung, Haotian Feng, Wen Zhao

Registry-linked trialOpen access · goldFull text read
In one paragraph

Article in Nutrition & metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04980599 (Effect of a Probiotic Strain Lactobacillus Paracasei K56 on Metabolic Symptom - a Pilot Study), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04980599 nacompletednot on this map

Effect of a Probiotic Strain Lactobacillus Paracasei K56 on Metabolic Symptom - a Pilot Study

TypeinterventionalSponsorFudan UniversityRan2021 to 2021Enrolled118ConditionsObesity, AdiposityArmsprobiotic drink with Lactobacillus paracasei K56, maltodextrin, Probiotic powder E3, Probiotic powder E5, probiotic capsule E7
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Journal of microbiology and biotechnology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Effects ofFrontiers in nutrition · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Guzailinuer KadeerDepartment of Nutrition, Hua Dong Hospital Affiliated to Fudan University, Shanghai, China.
Wanrui FuDepartment of Nutrition, Hua Dong Hospital Affiliated to Fudan University, Shanghai, China.
Yaqi HeDepartment of Nutrition, Hua Dong Hospital Affiliated to Fudan University, Shanghai, China.
Ying FengDepartment of Nutrition, Hua Dong Hospital Affiliated to Fudan University, Shanghai, China. yingfenghd@hotmail.com.
Wei-Hsein LiuInner Mongolia Yili Industrial Group Co., Ltd., Hohhot, China.
Wei-Lian HungInner Mongolia Yili Industrial Group Co., Ltd., Hohhot, China. hongweilian@yili.com.
Haotian FengInner Mongolia Yili Industrial Group Co., Ltd., Hohhot, China.
Wen ZhaoInner Mongolia Yili Industrial Group Co., Ltd., Hohhot, China.
Fudan University · CNInner Mongolia Yili Industrial Group (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies have shown that probiotics have an effect on reducing body fat on a strain-specific and dose-response bases. The purpose of this study was to evaluate the effect of a novel probiotic strain Lacticaseibacillus paracasei K56 on body fat and metabolic biomarkers in adult individuals with obesity.

methods74 adult subjects with obesity (body mass index ≥ 30 kg/m

resultsThe results showed that the L_K56 group had significant decreases in percent body fat (p = 0.004), visceral fat area (p = 0.0007), total body fat mass (p = 0.018), trunk body fat mass (p = 0.003), waist circumference (p = 0.003), glycosylated hemoglobin(p = 0.002) at the end of the study compared with baseline. There were non-significant reductions in Body weight and BMI in the L_K56, H_K56, VL_K56 groups, whereas increases were observed in the placebo and VH_K56 groups compared with baseline values. In addition, K56 supplementation modulated gut microbiota characteristics and diversity indices in the L-K56 group. However, mean changes in body fat mass, visceral fat area, weight, body mass index, waist circumference and hip circumference were not significantly different between groups.

conclusionsThe results suggest that supplementation with different doses of Lacticaseibacillus paracasei K56 has certain effect on reducing body fat and glycosylated hemoglobin, especially at a dose of 10

trial registrationclinicaltrials.gov Identifier: NCT04980599.

Indexed as

Body fatGut microbiotaLacticaseibacillus paracasei K56ObesityProbioticsVisceral fat area

Identifiers

PMID36944956
PMCPMC10031870
OpenAlexW4328130523

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read27
identifiers read1
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.